Skip to main content
Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX · Real-Time Price · USD
1.320
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
1.330
+0.010 (0.76%)
After-hours: Dec 20, 2024, 6:53 PM EST

Repare Therapeutics Revenue

Repare Therapeutics had revenue of $66.52M in the twelve months ending September 30, 2024, up 18.19% year-over-year. In the year 2023, Repare Therapeutics had annual revenue of $51.13M, down -61.21%.

Revenue (ttm)
$66.52M
Revenue Growth
+18.19%
P/S Ratio
0.84
Revenue / Employee
$371,642
Employees
179
Market Cap
56.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202351.13M-80.70M-61.21%
Dec 31, 2022131.83M124.23M1,634.61%
Dec 31, 20217.60M7.47M5,529.63%
Dec 31, 2020135.00K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareCloud 111.01M
Spero Therapeutics 106.46M
Aadi Bioscience 25.07M
Kronos Bio 9.86M
Dyadic International 3.36M
VolitionRx 1.29M
Revenue Rankings

RPTX News

More News